Glancing at the abstract as I don't access to the full article, but this study's population was very specific - "patients with extremity fractures that had been treated operatively or with any pelvic or acetabular fracture".
It would be interesting to see if aspirin continued to be noninferior in patients with conditions that were even more procoagulable, such as sepsis or covid. Does anyone happen to know if this is an active area of research being investigated in another conditions?
Hapgam t1_j7w07a3 wrote
Reply to According to a study on 12,211 patients, aspirin is just as effective at preventing blood clots as low molecular weight heparin, but it costs less and is easier to administer by giuliomagnifico
Glancing at the abstract as I don't access to the full article, but this study's population was very specific - "patients with extremity fractures that had been treated operatively or with any pelvic or acetabular fracture".
It would be interesting to see if aspirin continued to be noninferior in patients with conditions that were even more procoagulable, such as sepsis or covid. Does anyone happen to know if this is an active area of research being investigated in another conditions?